STRATA SKIN SCIENCES INC (SSKN) is a publicly traded Healthcare sector company. As of May 21, 2026, SSKN trades at $0.19 with a market cap of $0 and a P/E ratio of -0.07. SSKN moved -33.36% today. Year to date, SSKN is -79.37%; over the trailing twelve months it is -90.52%. Its 52-week range spans $0.12 to $3.86. Rallies surfaces SSKN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in SSKN news today?
Strata Skin Sciences Files Form 25, Plans Form 15 to Delist from Nasdaq: Strata Skin Sciences filed Form 25 to delist from Nasdaq on February 19 and will file Form 15 on March 2 to terminate SEC registration. The company ended fiscal 2025 with $8 million cash and anticipates cutting compliance costs to reduce burn and fund XTRAC and TheraclearX market expansion.
Rubinstein Samuel bought 2.17K (~$3.04K) on Nov 18, 2025.
Rubinstein Samuel bought 2.83K (~$3.99K) on Nov 18, 2025.
Rubinstein Samuel sold 5.50K (~$7.26K) on Nov 17, 2025.
SSKN Analyst Consensus
SSKN analyst coverage data. Average price target: $0.00.
Common questions about SSKN
What changed in SSKN news today?
Strata Skin Sciences Files Form 25, Plans Form 15 to Delist from Nasdaq: Strata Skin Sciences filed Form 25 to delist from Nasdaq on February 19 and will file Form 15 on March 2 to terminate SEC registration. The company ended fiscal 2025 with $8 million cash and anticipates cutting compliance costs to reduce burn and fund XTRAC and TheraclearX market expansion.
Does Rallies summarize SSKN news?
Yes. Rallies summarizes SSKN news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is SSKN research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SSKN. It does not provide personalized investment advice.
